<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Symptoms_Of_Ritonavir_You_Have_To_Know</id>
		<title>Symptoms Of Ritonavir You Have To Know - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Symptoms_Of_Ritonavir_You_Have_To_Know"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Symptoms_Of_Ritonavir_You_Have_To_Know&amp;action=history"/>
		<updated>2026-05-05T22:49:00Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Symptoms_Of_Ritonavir_You_Have_To_Know&amp;diff=120714&amp;oldid=prev</id>
		<title>Curleregypt6: Створена сторінка: 26 �� 0.32%, p[http://en.wikipedia.org/wiki/Ritonavir Ritonavir] (Tab. 2). The average PhIT was 0.99 �� 0.1. It was significantly lower comparing to the...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Symptoms_Of_Ritonavir_You_Have_To_Know&amp;diff=120714&amp;oldid=prev"/>
				<updated>2016-12-12T08:49:28Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: 26 �� 0.32%, p[http://en.wikipedia.org/wiki/Ritonavir Ritonavir] (Tab. 2). The average PhIT was 0.99 �� 0.1. It was significantly lower comparing to the...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;26 �� 0.32%, p[http://en.wikipedia.org/wiki/Ritonavir Ritonavir] (Tab. 2). The average PhIT was 0.99 �� 0.1. It was significantly lower comparing to the normal donors 1.83 �� 0.37, p0.05 (Fig. 3). There was no difference in the preoperative PhT% between [http://www.selleckchem.com/products/dabrafenib-gsk2118436.html Dabrafenib mw] patients from Group I and Group II, p=NS (Fig. 4). There was no difference in the preoperative PhIT of blood platelets between patients from Group I and Group II, p=NS (Fig. 5). Tab. 2 shows the average number of platelets, PhT% and PhIT in gastric cancer patients from Group I before the immunonutrition (GI1) and after the immunonutrition (GI2) and in normal donors (Control). After the immunonutrition the increase in platelets was observed, in the average of 798,923.0 �� 280,536.0/��l, p0.01. It was still significantly lower comparing to the normal donors (Tab. 2). Tab. 3 shows the average number of platelets, PhT% and PhIT in gastric cancer patients from Group II before the imunonutrition (GII1) and after the immunonutrition (GII2) and in normal donors (Control). After the immunonutrition the increased number of platelets was observed. An average one was 522,563.0 �� 233,595.0/��l, p&amp;gt;0.01 (Tab. 3). Also, the increase in the PhT% was observed, in the average of 1.1 �� 0.18%, p[http://www.selleckchem.com/products/sch772984.html www.selleckchem.com/products/sch772984.html] significantly, in the average of 1.06 �� 0.11, p&lt;/div&gt;</summary>
		<author><name>Curleregypt6</name></author>	</entry>

	</feed>